A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases.
A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases.
New research from Emory University is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.
New research led by Eric Sundberg of Emory’s School of Medicine highlights the therapeutic potential of an enzyme in managing immune-related disorders. The discovery could mean more effective drugs for patients.
Emory researcher David Weiss has spent years studying a baffling phenomenon called heteroresistance, in which a tiny fraction of bacteria remain resistant to antibiotics, while the remainder succumb. Recently, he brought his scientific acumen to the equally deadly threat of fungal bloodstream infections in patients receiving bone marrow transplants.
Emory partners with University of Queensland to accelerate the development and delivery of vaccines.
Emory professor Max Cooper’s historic discoveries forever changed our understanding of the adaptive immune system, fueling lifesaving advances in basic research and medicine. The annual award in his honor is open to national and international candidates across the spectrum of immunology.
Emory Vaccine Center researchers have identified a potential Achilles heel within SARS-CoV-2. The vulnerable spot can be targeted with a peptide derived from wild boar, which maintains its antiviral activity across known variants.
The Cancer Research Institute has awarded a five-year STAR program grant of $1.25 million to Haydn T. Kissick, PhD, assistant professor in the Emory School of Medicine and Cancer Immunology researcher at Emory’s Winship Cancer Institute, to search for answers to the difficult question of how T cells can help protect the body against cancer.
The 2023 Albert E. Levy Award for Excellence in Scientific Research went to Jennifer Strafford Stevens and Guido Silvestri in recognition of their groundbreaking research and advancement of scientific knowledge.
New findings from a meta-analysis published in Nature Immunology examine the biological mechanisms responsible for why some people’s immune systems respond differently to vaccinations.
In the SAVE program, researchers assess whether mutations in emerging SARS-CoV-2 variants such as Delta and Omicron affect virus transmission, severity and immunity, which in turn supports the testing of vaccines and therapeutics and guides public health responses.
Bacteria inside our guts are fine-tuning our metabolism. Emory researchers have identified an obesity-promoting chemical produced by intestinal bacteria.
Emory University ranked 20th out of 796 U.S. universities according to the 2022 Wall Street Journal/Times Higher Education College Rankings, published Sept. 21.
The Lupus Research Alliance has awarded one of its largest grants to date to a team led by Emory immunologist Ignacio Sanz, MD. The $3 million project will focus on immune cells that produce autoantibodies, specifically in African American patients.
An Emory University-led research collaboration has been awarded a five-year, $23.8 million grant from the National Institutes of Health to fast-track research to cure HIV infection or put it in permanent remission.
The immune cells that are the major targets of immune checkpoint inhibitors are present in HPV+ tumors from head and neck cancer patients, a Winship/Emory Vaccine Center study reports.
NIAID has awarded Emory researchers a five-year, $11 million dollar grant to study heteroresistance, a stealthy form of antibiotic resistance that undermines the treatment of bacterial infections.
A more contagious coronavirus variant known as B.1.1.7 is still susceptible to antibodies induced after COVID-19 infection or vaccination. But another called B.1.351 modestly reduces antibodies' potency.
Researchers at Yerkes National Primate Research Center and Emory Vaccine Center have developed a COVID-19 vaccine that has proven safe and effective in mice and monkeys.
The National Cancer Institute has awarded a five-year, $9.9 million grant to Emory investigators to study COVID-19 immune responses in patients with cancer or autoimmune diseases.